effects of arachidonic acid on myosin ATPase activity and contraction of smooth muscle via myosin motor domain. Am J Physiol Heart Circ Physiol 298: H505-H514, 2010. First published November 20, 2009 doi:10.1152/ajpheart.00577.2009.-We have been searching for a mechanism to induce smooth muscle contraction that is not associated with phosphorylation of the regulatory light chain (RLC) of smooth muscle myosin (Nakamura A, Xie C, Zhang Y, Gao Y, Wang HH, Ye LH, Kishi H, Okagaki T, Yoshiyama S, Hayakawa K, Ishikawa R, Kohama K. Biochem Biophys Res Commun 369: [135][136][137][138][139][140][141][142][143] 2008). In this article, we report that arachidonic acid (AA) stimulates ATPase activity of unphosphorylated smooth muscle myosin with maximal stimulation (Rmax) of 6.84 Ϯ 0.51 relative to stimulation by the vehicle and with a half-maximal effective concentration (EC50) of 50.3 Ϯ 4.2 M. In the presence of actin, Rmax was 1.72 Ϯ 0.08 and EC50 was 26.3 Ϯ 2.3 M. Our experiments with eicosanoids consisting of the AA cascade suggested that they neither stimulated nor inhibited the activity. Under conditions that did not allow RLC to be phosphorylated, AA stimulated contraction of smooth muscle tissue with an Rmax of 1.45 Ϯ 0.07 and an EC50 of 27.0 Ϯ 4.4 M. In addition to the ATPase activities of the myosin, AA stimulated those of heavy meromyosin, subfragment 1 (S1), S1 from which the RLC was removed, and a recombinant heavy chain consisting of the myosin head. The stimulatory effects of AA on these preparations were about twofold. The site of AA action was indicated to be the step-releasing inorganic phosphate (Pi) from the reaction intermediate of the myosin-ADP-Pi complex. The enhancement of Pi release by AA was supported by computer simulation indicating that AA docked in the actin-binding cleft of the myosin motor domain. The stimulatory effect of AA was detectable with both unphosphorylated myosin and the myosin in which RLC was fully phosphorylated. The AA effect on both myosin forms was suggested to cause excess contraction such as vasospasm. . Myosin with unphosphorylated RLC exhibits a folded monomeric conformation (41,46,54). The fold of the tail part of the heavy chain is commonly observed in the RLC region, and the tail of the heavy chain is extended when the RLC is phosphorylated (6). The phosphorylated myosin assembles into the myosin filaments that are commonly observed in smooth muscle, including vascular smooth muscle (VSM) cells. Therefore, the RLC is thought to play a key role in regulation of structure and function of the myosin (54). Arachidonic acid (AA) is one of the bioactive lipids and is produced in eukaryotic cells mainly through the catalytic action of phospholipase A 2 , although a few other mechanisms are known, and it is then further processed by cyclooxygenase (COX), lipoxygenase, and P-450 enzymes to yield metabolites. They are secreted outside of the cells and bind to their respective receptors of the target cells (37, 49). In the cytoplasm of the cells, AA itself can stimulate a few e...